Skip header and navigation

Refine By

19 records – page 1 of 2.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

https://arctichealth.org/en/permalink/ahliterature163301
Source
Can J Cardiol. 2007 May 15;23(7):529-38
Publication Type
Conference/Meeting Material
Article
Date
May-15-2007
Author
Raj S Padwal
Brenda R Hemmelgarn
Finlay A McAlister
Donald W McKay
Steven Grover
Thomas Wilson
Brian Penner
Ellen Burgess
Peter Bolli
Michael Hill
Jeff Mahon
Martin G Myers
Carl Abbott
Ernest L Schiffrin
George Honos
Karen Mann
Guy Tremblay
Alain Milot
Lyne Cloutier
Arun Chockalingam
Nadia A Khan
Simon W Rabkin
Martin Dawes
Rhian M Touyz
Sheldon W Tobe
Author Affiliation
Division of General Internal Medicine, University of Alberta, Edmonton, Alberta. rpadwal@ualberta.ca
Source
Can J Cardiol. 2007 May 15;23(7):529-38
Date
May-15-2007
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Blood Pressure Determination
Blood Pressure Monitoring, Ambulatory
Canada
Health promotion
Humans
Hypertension - diagnosis - physiopathology - prevention & control
Patient Education as Topic
Risk factors
Abstract
To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension.
The diagnosis of hypertension is dependent on the appropriate measurement of blood pressure, the timely assessment of serially elevated readings, the degree of blood pressure elevation, the method of measurement (office, ambulatory, home) and any associated comorbidities. The presence of cardiovascular risk factors and target organ damage should be ascertained to assess global cardiovascular risk, and to determine the urgency, intensity and type of treatment required.
MEDLINE searches were conducted from November 2005 to October 2006 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based on evidence from peer-reviewed, full-text articles only.
Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis of renovascular and endocrine causes of hypertension, home and ambulatory monitoring, and the use of echocardiography in hypertensive individuals are outlined. Key messages in 2007 include continued emphasis on the expedited, accurate diagnosis of hypertension, the importance of assessing the risk of cerebrovascular events as part of global risk assessment, the need for ongoing reassessment of patients with high normal blood pressure, and reviews of recent studies involving laboratory testing and home monitoring.
All recommendations were graded according to strength of the evidence and were voted on by the 57 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations reported here received at least 70% consensus. These guidelines will continue to be updated annually.
Notes
Cites: Lancet. 2001 Nov 17;358(9294):1682-611728544
Cites: Clin Sci (Lond). 2001 Dec;101(6):671-911724655
Cites: J Hypertens. 2002 Apr;20(4):579-8111910284
Cites: Stroke. 2002 Jul;33(7):1776-8112105351
Cites: Can J Cardiol. 2002 Jun;18(6):604-2412107419
Cites: Can J Cardiol. 2002 Jun;18(6):625-4112107420
Cites: Blood Press Monit. 2002 Dec;7(6):293-30012488648
Cites: Lancet. 2002 Dec 14;360(9349):1903-1312493255
Cites: Eur Heart J. 2003 Jun;24(11):987-100312788299
Cites: Hypertension. 2004 Jan;43(1):10-714638619
Cites: Can J Cardiol. 2004 Jan;20(1):31-4014968141
Cites: Can J Cardiol. 2004 Jan;20(1):41-5414968142
Cites: JAMA. 2004 Mar 17;291(11):1342-915026401
Cites: Lancet. 2004 Sep 11-17;364(9438):937-5215364185
Cites: Circulation. 1991 Jan;83(1):356-621984895
Cites: JAMA. 1996 May 22-29;275(20):1571-68622248
Cites: Arch Intern Med. 1996 Jul 8;156(13):1414-208678709
Cites: Arch Intern Med. 1998 Mar 23;158(6):655-629521231
Cites: Am J Epidemiol. 2004 Dec 1;160(11):1122-3115561992
Cites: Can J Cardiol. 2005 Jun;21(8):645-5616003448
Cites: Can J Cardiol. 2005 Jun;21(8):657-7216003449
Cites: Arch Intern Med. 2005 Jul 11;165(13):1541-616009871
Cites: Kidney Int. 2006 Jan;69(2):406-1116408134
Cites: J Hypertens. 2006 Apr;24(4):775-8116531808
Cites: N Engl J Med. 2006 Apr 20;354(16):1685-9716537662
Cites: Hypertension. 2006 May;47(5):846-5316567588
Cites: Can J Cardiol. 2006 May 15;22(7):559-6416755310
Cites: Can J Cardiol. 2006 May 15;22(7):573-8116755312
Cites: Can J Cardiol. 2006 May 15;22(7):583-9316755313
Cites: Can J Cardiol. 2006 May 15;22(7):606-1316755316
Cites: Am J Epidemiol. 2006 Oct 15;164(8):725-716936069
Cites: Lancet. 2003 Nov 29;362(9398):1776-714654312
Cites: Can J Cardiol. 2001 Dec;17(12):1249-6311773936
Cites: Am Heart J. 2000 Feb;139(2 Pt 1):272-8110650300
Cites: Arch Intern Med. 2000 Mar 13;160(5):685-9310724055
Cites: Clin Radiol. 2000 May;55(5):346-5310816399
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: BMJ. 2001 Apr 21;322(7292):977-8011312234
Cites: Can J Cardiol. 2001 May;17(5):543-5911381277
Cites: JAMA. 2001 Jul 11;286(2):180-711448281
Cites: N Engl J Med. 2001 Nov 1;345(18):1291-711794147
Comment In: Can J Cardiol. 2007 May 15;23(7):603-417593584
PubMed ID
17534459 View in PubMed
Less detail

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.

https://arctichealth.org/en/permalink/ahliterature156767
Source
Can J Cardiol. 2008 Jun;24(6):455-63
Publication Type
Article
Date
Jun-2008
Author
Raj S Padwal
Brenda R Hemmelgarn
Nadia A Khan
Steven Grover
Finlay A McAlister
Donald W McKay
Thomas Wilson
Brian Penner
Ellen Burgess
Peter Bolli
Michael D Hill
Jeff Mahon
Martin G Myers
Carl Abbott
Ernesto L Schiffrin
George Honos
Karen Mann
Guy Tremblay
Alain Milot
Lyne Cloutier
Arun Chockalingam
Simon W Rabkin
Martin Dawes Dawes
Rhian M Touyz
Chaim Bell
Kevin D Burns
Marcel Ruzicka
Norman R C Campbell
Marcel Lebel
Sheldon W Tobe
Author Affiliation
Division of General Internal Medicine, University of Alberta, Edmonton, Canada. rpadwal@ualberta.ca
Source
Can J Cardiol. 2008 Jun;24(6):455-63
Date
Jun-2008
Language
English
Publication Type
Article
Keywords
Antihypertensive Agents - therapeutic use
Blood Pressure - physiology
Blood Pressure Determination - standards
Canada
Clinical Competence
Diagnosis, Differential
Education, Medical, Continuing - standards
Humans
Hypertension - diagnosis - drug therapy - physiopathology
Practice Guidelines as Topic
Program Evaluation - trends
Risk Assessment - methods
Abstract
To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension.
The diagnosis of hypertension is dependent on appropriate blood pressure measurement, the timely assessment of serially elevated readings, degree of blood pressure elevation, method of measurement (office, ambulatory, home) and associated comorbidities. The presence of cardiovascular risk factors and target organ damage should be ascertained to assess global cardiovascular risk and determine the urgency, intensity and type of treatment required.
MEDLINE searches were conducted from November 2006 to October 2007 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based on evidence from peer-reviewed, full-text articles only.
Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis of renovascular and endocrine causes of hypertension, home and ambulatory monitoring, and the use of echocardiography in hypertensive individuals are outlined. Key messages in 2008 include continued emphasis on the expedited, accurate diagnosis of hypertension, the importance of global risk assessment and the need for ongoing monitoring of hypertensive patients to identify incident type 2 diabetes.
All recommendations were graded according to strength of the evidence and voted on by the 57 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations reported here received at least 70% consensus. These guidelines will continue to be updated annually.
Notes
Cites: Am Heart J. 2000 Feb;139(2 Pt 1):272-8110650300
Cites: Arch Intern Med. 2007 Nov 26;167(21):2296-30318039987
Cites: Clin Radiol. 2000 May;55(5):346-5310816399
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: JAMA. 2001 Jul 11;286(2):180-711448281
Cites: Clin Sci (Lond). 2001 Dec;101(6):671-911724655
Cites: Stroke. 2002 Jul;33(7):1776-8112105351
Cites: Lancet. 2002 Dec 14;360(9349):1903-1312493255
Cites: Lancet. 2003 Apr 5;361(9364):1149-5812686036
Cites: Eur Heart J. 2003 Jun;24(11):987-100312788299
Cites: Lancet. 2003 Nov 29;362(9398):1776-714654312
Cites: Diabetes Care. 2004 Jan;27(1):247-5514693997
Cites: Hypertension. 2004 Jan;43(1):10-714638619
Cites: Hypertension. 2004 May;43(5):963-915037557
Cites: Lancet. 2004 Sep 11-17;364(9438):937-5215364185
Cites: Circulation. 1991 Jan;83(1):356-621984895
Cites: JAMA. 1996 May 22-29;275(20):1571-68622248
Cites: Arch Intern Med. 1996 Jul 8;156(13):1414-208678709
Cites: Arch Intern Med. 1998 Mar 23;158(6):655-629521231
Cites: Am J Cardiol. 2005 Jan 1;95(1):29-3515619390
Cites: Can J Cardiol. 2005 Jun;21(8):645-5616003448
Cites: Can J Cardiol. 2006 May 15;22(7):559-6416755310
Cites: Can J Cardiol. 2006 May 15;22(7):573-8116755312
Cites: Can J Cardiol. 2006 May 15;22(7):606-1316755316
Cites: Hypertension. 2006 Aug;48(2):219-2416801488
Cites: N Engl J Med. 2006 Oct 12;355(15):1551-6216980380
Cites: Arch Intern Med. 2006 Nov 13;166(20):2191-20117101936
Cites: Lancet. 2007 Jan 20;369(9557):201-717240286
Cites: AJR Am J Roentgenol. 2007 Mar;188(3):798-81117312071
Cites: Can J Cardiol. 2007 May 15;23(7):529-3817534459
Cites: Can J Cardiol. 2007 May 15;23(7):539-5017534460
Cites: J Hypertens. 2007 Jun;25(6):1311-717563546
Cites: Kidney Int. 2007 Aug;72(3):260-417507905
Cites: Hypertension. 2007 Sep;50(3):467-7317679652
Cites: N Engl J Med. 2000 Mar 30;342(13):905-1210738048
PubMed ID
18548142 View in PubMed
Less detail

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk.

https://arctichealth.org/en/permalink/ahliterature151165
Source
Can J Cardiol. 2009 May;25(5):279-86
Publication Type
Article
Date
May-2009
Author
Raj S Padwal
Brenda R Hemmelgarn
Nadia A Khan
Steven Grover
Donald W McKay
Thomas Wilson
Brian Penner
Ellen Burgess
Finlay A McAlister
Peter Bolli
Machael D Hill
Jeff Mahon
Martin G Myers
Carl Abbott
Ernesto L Schiffrin
George Honos
Karen Mann
Guy Tremblay
Alain Milot
Lyne Cloutier
Arun Chockalingam
Simon W Rabkin
Martin Dawes
Rhian M Touyz
Chaim Bell
Kevin D Burns
Marcel Ruzicka
Norman R C Campbell
Michel Vallée
Ramesh Prasad
Marcel Lebel
Sheldon W Tobe
Author Affiliation
Division of General Internal Medicine, University of Alberta, Edmonton, Canada. rpadwal@ualberta.ca
Source
Can J Cardiol. 2009 May;25(5):279-86
Date
May-2009
Language
English
Publication Type
Article
Keywords
Adult
Aged
Antihypertensive Agents - therapeutic use
Blood Pressure Determination - standards
Canada
Clinical Competence
Combined Modality Therapy
Education, Medical, Continuing - standards
Female
Guideline Adherence
Health Promotion - organization & administration
Humans
Hypertension - diagnosis - therapy
Life Style
Male
Middle Aged
Prognosis
Randomized Controlled Trials as Topic
Risk Management
Treatment Outcome
Abstract
To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension.
The diagnosis of hypertension is dependent on appropriate blood pressure measurement, the timely assessment of serially elevated readings, the degree of blood pressure elevation, the method of measurement (office, ambulatory, home) and associated comorbidities. The presence of cardiovascular risk factors and target organ damage should be ascertained to assess global cardiovascular risk and determine the urgency, intensity and type of treatment required.
MEDLINE searches were conducted from November 2007 to October 2008 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based on evidence from peer-reviewed full-text articles only.
Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis of renovascular and endocrine causes of hypertension, home and ambulatory monitoring, and the use of echocardiography in hypertensive individuals are outlined. Key messages include continued emphasis on the expedited, accurate diagnosis of hypertension, the importance of global risk assessment and the need for ongoing monitoring of hypertensive patients to identify incident type 2 diabetes.
All recommendations were graded according to strength of the evidence and voted on by the 57 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations were required to be supported by at least 70% of task force members. These guidelines will continue to be updated annually.
Notes
Cites: Diabetes Care. 2004 Jan;27(1):247-5514693997
Cites: JAMA. 2008 Jul 9;300(2):197-20818612117
Cites: Hypertension. 2004 May;43(5):963-915037557
Cites: Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-7615286277
Cites: Lancet. 2004 Sep 11-17;364(9438):937-5215364185
Cites: Circulation. 1991 Jan;83(1):356-621984895
Cites: JAMA. 1996 May 22-29;275(20):1571-68622248
Cites: Arch Intern Med. 1996 Jul 8;156(13):1414-208678709
Cites: Arch Intern Med. 1998 Mar 23;158(6):655-629521231
Cites: Am J Cardiol. 2005 Jan 1;95(1):29-3515619390
Cites: Can J Cardiol. 2005 Jun;21(8):645-5616003448
Cites: Can J Cardiol. 2006 May 15;22(7):559-6416755310
Cites: Can J Cardiol. 2006 May 15;22(7):573-8116755312
Cites: Can J Cardiol. 2006 May 15;22(7):606-1316755316
Cites: N Engl J Med. 2006 Oct 12;355(15):1551-6216980380
Cites: Arch Intern Med. 2006 Nov 13;166(20):2191-20117101936
Cites: Lancet. 2007 Jan 20;369(9557):201-717240286
Cites: AJR Am J Roentgenol. 2007 Mar;188(3):798-81117312071
Cites: Can J Cardiol. 2007 May 15;23(7):529-3817534459
Cites: Can J Cardiol. 2007 May 15;23(7):539-5017534460
Cites: J Hypertens. 2007 Jun;25(6):1311-717563546
Cites: Kidney Int. 2007 Aug;72(3):260-417507905
Cites: Hypertension. 2007 Sep;50(3):467-7317679652
Cites: Am Heart J. 2000 Feb;139(2 Pt 1):272-8110650300
Cites: N Engl J Med. 2000 Mar 30;342(13):905-1210738048
Cites: Clin Radiol. 2000 May;55(5):346-5310816399
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: JAMA. 2001 Jul 11;286(2):180-711448281
Cites: Clin Sci (Lond). 2001 Dec;101(6):671-911724655
Cites: Stroke. 2002 Jul;33(7):1776-8112105351
Cites: Lancet. 2002 Dec 14;360(9349):1903-1312493255
Cites: Lancet. 2003 Apr 5;361(9364):1149-5812686036
Cites: Eur Heart J. 2003 Jun;24(11):987-100312788299
Cites: Lancet. 2003 Nov 29;362(9398):1776-714654312
Cites: Arch Intern Med. 2007 Nov 26;167(21):2296-30318039987
Cites: Can J Cardiol. 2008 Jun;24(6):455-6318548142
Cites: Can J Cardiol. 2008 Jun;24(6):465-7518548143
Cites: Hypertension. 2004 Jan;43(1):10-714638619
PubMed ID
19417858 View in PubMed
Less detail

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.

https://arctichealth.org/en/permalink/ahliterature143445
Source
Can J Cardiol. 2010 May;26(5):241-8
Publication Type
Article
Date
May-2010
Author
Robert R Quinn
Brenda R Hemmelgarn
Raj S Padwal
Martin G Myers
Lyne Cloutier
Peter Bolli
Donald W McKay
Nadia A Khan
Michael D Hill
Jeff Mahon
Daniel G Hackam
Steven Grover
Thomas Wilson
Brian Penner
Ellen Burgess
Finlay A McAlister
Maxime Lamarre-Cliche
Donna McLean
Ernesto L Schiffrin
George Honos
Karen Mann
Guy Tremblay
Alain Milot
Arun Chockalingam
Simon W Rabkin
Martin Dawes
Rhian M Touyz
Kevin D Burns
Marcel Ruzicka
Norman R C Campbell
Michel Vallée
G V Ramesh Prasad
Marcel Lebel
Sheldon W Tobe
Author Affiliation
Division of Nephrology, University of Calgary, Alberta. rob.quinn@albertahealthservices.ca
Source
Can J Cardiol. 2010 May;26(5):241-8
Date
May-2010
Language
English
Publication Type
Article
Keywords
Adult
Aged
Blood Pressure Determination - standards
Blood Pressure Monitoring, Ambulatory - standards
Canada
Cardiovascular Diseases - epidemiology - prevention & control
Female
Humans
Hypertension - diagnosis - epidemiology
Male
Middle Aged
Physician's Practice Patterns
Practice Guidelines as Topic
Quality of Health Care
Risk assessment
Abstract
To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension.
MEDLINE searches were conducted from November 2008 to October 2009 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based on evidence from peer-reviewed full-text articles only.
Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis of renovascular and endocrine causes of hypertension, home and ambulatory monitoring, and the use of echocardiography in hypertensive individuals are outlined. Changes to the recommendations for 2010 relate to automated office blood pressure measurements. Automated office blood pressure measurements can be used in the assessment of office blood pressure. When used under proper conditions, an automated office systolic blood pressure of 135 mmHg or higher or diastolic blood pressure of 85 mmHg or higher should be considered analogous to a mean awake ambulatory systolic blood pressure of 135 mmHg or higher and diastolic blood pressure of 85 mmHg or higher, respectively.
All recommendations were graded according to strength of the evidence and voted on by the 63 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. To be approved, all recommendations were required to be supported by at least 70% of task force members. These guidelines will continue to be updated annually.
Notes
Cites: Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-7615286277
Cites: Can J Cardiol. 2007 May 15;23(7):529-3817534459
Cites: Circulation. 1991 Jan;83(1):356-621984895
Cites: JAMA. 1996 May 22-29;275(20):1571-68622248
Cites: Arch Intern Med. 1996 Jul 8;156(13):1414-208678709
Cites: Arch Intern Med. 1998 Mar 23;158(6):655-629521231
Cites: BMC Cardiovasc Disord. 2005;5(1):1815985180
Cites: Can J Cardiol. 2005 Jun;21(8):645-5616003448
Cites: Blood Press Monit. 2005 Oct;10(5):257-6216205444
Cites: Can J Cardiol. 2007 May 15;23(7):539-5017534460
Cites: J Hum Hypertens. 2007 Jul;21(7):588-9017377600
Cites: Arch Intern Med. 2007 Nov 26;167(21):2296-30318039987
Cites: Am J Hypertens. 2008 Mar;21(3):280-318219304
Cites: Can J Cardiol. 2008 Jun;24(6):455-6318548142
Cites: Can J Cardiol. 2008 Jun;24(6):465-7518548143
Cites: JAMA. 2008 Jul 9;300(2):197-20818612117
Cites: Blood Press Monit. 2008 Oct;13(5):299-30318799957
Cites: Int J Clin Pract. 2008 Oct;62(10):1484-9818691228
Cites: J Hypertens. 2009 Feb;27(2):280-619155785
Cites: Can J Cardiol. 2009 May;25(5):279-8619417858
Cites: Can J Cardiol. 2009 May;25(5):287-9819417859
Cites: Blood Press Monit. 2009 Jun;14(3):108-1119417634
Cites: J Am Coll Cardiol. 2009 Sep 29;54(14):1209-2719778661
Cites: Am Heart J. 2000 Feb;139(2 Pt 1):272-8110650300
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: Blood Press Monit. 2001 Apr;6(2):107-1011433132
Cites: JAMA. 2001 Jul 11;286(2):180-711448281
Cites: Blood Press Monit. 2001 Jun;6(3):161-511518840
Cites: Lancet. 2002 Dec 14;360(9349):1903-1312493255
Cites: Eur Heart J. 2003 Jun;24(11):987-100312788299
Cites: Lancet. 2003 Nov 29;362(9398):1776-714654312
Cites: Hypertension. 2004 Jan;43(1):10-714638619
Cites: Blood Press Monit. 2006 Apr;11(2):59-6216534406
Cites: Can J Cardiol. 2006 May 15;22(7):559-6416755310
Cites: Can J Cardiol. 2006 May 15;22(7):573-8116755312
Cites: Can J Cardiol. 2006 May 15;22(7):606-1316755316
Cites: J Clin Hypertens (Greenwich). 2007 Apr;9(4):267-7017396069
Cites: Lancet. 2004 Sep 11-17;364(9438):937-5215364185
PubMed ID
20485688 View in PubMed
Less detail

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

https://arctichealth.org/en/permalink/ahliterature132607
Source
Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2
Publication Type
Article
Author
Doreen M Rabi
Stella S Daskalopoulou
Raj S Padwal
Nadia A Khan
Steven A Grover
Daniel G Hackam
Martin G Myers
Donald W McKay
Robert R Quinn
Brenda R Hemmelgarn
Lyne Cloutier
Peter Bolli
Michael D Hill
Thomas Wilson
Brian Penner
Ellen Burgess
Maxime Lamarre-Cliché
Donna McLean
Ernesto L Schiffrin
George Honos
Karen Mann
Guy Tremblay
Alain Milot
Arun Chockalingam
Simon W Rabkin
Martin Dawes
Rhian M Touyz
Kevin D Burns
Marcel Ruzicka
Norman R C Campbell
Michel Vallée
G V Ramesh Prasad
Marcel Lebel
Tavis S Campbell
M Patrice Lindsay
Robert J Herman
Pierre Larochelle
Ross D Feldman
J Malcolm O Arnold
Gordon W Moe
Jonathan G Howlett
Luc Trudeau
Simon L Bacon
Robert J Petrella
Richard Lewanczuk
James A Stone
Denis Drouin
Jean-Martin Boulanger
Mukul Sharma
Pavel Hamet
George Fodor
George K Dresser
S George Carruthers
George Pylypchuk
Richard E Gilbert
Lawrence A Leiter
Charlotte Jones
Richard I Ogilvie
Vincent Woo
Philip A McFarlane
Robert A Hegele
Luc Poirier
Sheldon W Tobe
Author Affiliation
Department of Medicine, University of Calgary, Calgary, Alberta, Canada. doreen.rabi@albertahealthservices.ca
Source
Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2
Language
English
French
Publication Type
Article
Keywords
Adult
Antihypertensive Agents - therapeutic use
Blood Pressure Determination
Canada
Health education
Humans
Hypertension - diagnosis - drug therapy
Risk assessment
Abstract
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2011. The major guideline changes this year are: (1) a recommendation was made for using comparative risk analogies when communicating a patient's cardiovascular risk; (2) diagnostic testing issues for renal artery stenosis were discussed; (3) recommendations were added for the management of hypertension during the acute phase of stroke; (4) people with hypertension and diabetes are now considered high risk for cardiovascular events if they have elevated urinary albumin excretion, overt kidney disease, cardiovascular disease, or the presence of other cardiovascular risk factors; (5) the combination of an angiotensin-converting enzyme (ACE) inhibitor and a dihydropyridine calcium channel blocker (CCB) is preferred over the combination of an ACE inhibitor and a thiazide diuretic in persons with diabetes and hypertension; and (6) a recommendation was made to coordinate with pharmacists to improve antihypertensive medication adherence. We also discussed the recent analyses that examined the association between angiotensin II receptor blockers (ARBs) and cancer.
PubMed ID
21801975 View in PubMed
Less detail

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

https://arctichealth.org/en/permalink/ahliterature124290
Source
Can J Cardiol. 2012 May;28(3):270-87
Publication Type
Article
Date
May-2012
Author
Stella S Daskalopoulou
Nadia A Khan
Robert R Quinn
Marcel Ruzicka
Donald W McKay
Daniel G Hackam
Simon W Rabkin
Doreen M Rabi
Richard E Gilbert
Raj S Padwal
Martin Dawes
Rhian M Touyz
Tavis S Campbell
Lyne Cloutier
Steven Grover
George Honos
Robert J Herman
Ernesto L Schiffrin
Peter Bolli
Thomas Wilson
Ross D Feldman
M Patrice Lindsay
Brenda R Hemmelgarn
Michael D Hill
Mark Gelfer
Kevin D Burns
Michel Vallée
G V Ramesh Prasad
Marcel Lebel
Donna McLean
J Malcolm O Arnold
Gordon W Moe
Jonathan G Howlett
Jean-Martin Boulanger
Pierre Larochelle
Lawrence A Leiter
Charlotte Jones
Richard I Ogilvie
Vincent Woo
Janusz Kaczorowski
Luc Trudeau
Simon L Bacon
Robert J Petrella
Alain Milot
James A Stone
Denis Drouin
Maxime Lamarre-Cliché
Marshall Godwin
Guy Tremblay
Pavel Hamet
George Fodor
S George Carruthers
George Pylypchuk
Ellen Burgess
Richard Lewanczuk
George K Dresser
Brian Penner
Robert A Hegele
Philip A McFarlane
Mukul Sharma
Norman R C Campbell
Debra Reid
Luc Poirier
Sheldon W Tobe
Author Affiliation
Division of General Internal Medicine, McGill University, Montreal, Québec, Canada. stella.daskalopoulou@mcgill.ca
Source
Can J Cardiol. 2012 May;28(3):270-87
Date
May-2012
Language
English
Publication Type
Article
Keywords
Adult
Aged
Antihypertensive Agents - therapeutic use
Blood Pressure Determination - methods
Canada
Cardiovascular Diseases - etiology - prevention & control
Education, Medical, Continuing - standards
Evidence-Based Medicine - standards
Female
Health Education - standards
Humans
Hypertension - complications - diagnosis - therapy
Male
Middle Aged
Monitoring, Physiologic - methods
Practice Guidelines as Topic - standards
Prognosis
Risk assessment
Treatment Outcome
Abstract
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2012. The new recommendations are: (1) use of home blood pressure monitoring to confirm a diagnosis of white coat syndrome; (2) mineralocorticoid receptor antagonists may be used in selected patients with hypertension and systolic heart failure; (3) a history of atrial fibrillation in patients with hypertension should not be a factor in deciding to prescribe an angiotensin-receptor blocker for the treatment of hypertension; and (4) the blood pressure target for patients with nondiabetic chronic kidney disease has now been changed to
PubMed ID
22595447 View in PubMed
Less detail

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

https://arctichealth.org/en/permalink/ahliterature115112
Source
Can J Cardiol. 2013 May;29(5):528-42
Publication Type
Article
Date
May-2013
Author
Daniel G Hackam
Robert R Quinn
Pietro Ravani
Doreen M Rabi
Kaberi Dasgupta
Stella S Daskalopoulou
Nadia A Khan
Robert J Herman
Simon L Bacon
Lyne Cloutier
Martin Dawes
Simon W Rabkin
Richard E Gilbert
Marcel Ruzicka
Donald W McKay
Tavis S Campbell
Steven Grover
George Honos
Ernesto L Schiffrin
Peter Bolli
Thomas W Wilson
Ross D Feldman
Patrice Lindsay
Michael D Hill
Mark Gelfer
Kevin D Burns
Michel Vallée
G V Ramesh Prasad
Marcel Lebel
Donna McLean
J Malcolm O Arnold
Gordon W Moe
Jonathan G Howlett
Jean-Martin Boulanger
Pierre Larochelle
Lawrence A Leiter
Charlotte Jones
Richard I Ogilvie
Vincent Woo
Janusz Kaczorowski
Luc Trudeau
Robert J Petrella
Alain Milot
James A Stone
Denis Drouin
Kim L Lavoie
Maxime Lamarre-Cliche
Marshall Godwin
Guy Tremblay
Pavel Hamet
George Fodor
S George Carruthers
George B Pylypchuk
Ellen Burgess
Richard Lewanczuk
George K Dresser
S Brian Penner
Robert A Hegele
Philip A McFarlane
Mukul Sharma
Debra J Reid
Sheldon W Tobe
Luc Poirier
Raj S Padwal
Author Affiliation
Division of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario, Canada. dhackam@uwo.ca
Source
Can J Cardiol. 2013 May;29(5):528-42
Date
May-2013
Language
English
Publication Type
Article
Keywords
Adult
Aging - physiology
Antihypertensive Agents - therapeutic use
Blood Pressure - physiology
Blood Pressure Determination
Canada
Cardiovascular Diseases - prevention & control
Exercise - physiology
Health education
Humans
Hypertension - diagnosis - drug therapy
Risk assessment
Abstract
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2013. This year's update includes 2 new recommendations. First, among nonhypertensive or stage 1 hypertensive individuals, the use of resistance or weight training exercise does not adversely influence blood pressure (BP) (Grade D). Thus, such patients need not avoid this type of exercise for fear of increasing BP. Second, and separately, for very elderly patients with isolated systolic hypertension (age 80 years or older), the target for systolic BP should be
PubMed ID
23541660 View in PubMed
Less detail

Barriers to the implementation of practice guidelines in managing patients with nonvariceal upper gastrointestinal bleeding: A qualitative approach.

https://arctichealth.org/en/permalink/ahliterature143438
Source
Can J Gastroenterol. 2010 May;24(5):289-96
Publication Type
Article
Date
May-2010
Author
Sean M Hayes
Suzanne Murray
Martin Dupuis
Martin Dawes
Ian A Hawes
Alan N Barkun
Author Affiliation
AXDEV Group Inc, Brossard, Quebec. hayess@axdevgroup.com
Source
Can J Gastroenterol. 2010 May;24(5):289-96
Date
May-2010
Language
English
Publication Type
Article
Keywords
Canada
Gastrointestinal Hemorrhage - etiology - therapy
Guideline Adherence - utilization
Hemostatic Techniques - standards
Humans
Outcome Assessment (Health Care)
Practice Guidelines as Topic
Abstract
Guidelines for the management of patients with nonvariceal upper gastrointestinal bleeding (NVUGIB) are inconsistently applied by health care providers, potentially resulting in suboptimal care and patient outcomes. A needs assessment was performed to assess health care providers' barriers to the implementation of these guidelines in Canada.
Semistructured telephone interviews were conducted by trained research personnel with 22 selectively sampled health care professionals actively treating and managing NVUGIB patients, including emergency room physicians (ER), intensivists (ICU), gastroenterologists (GI), gastroenterology nurses and hospital administrators. Participants were chosen from a representative sample of six Canadian community- and academic-based hospitals that participated in a national Canadian audit on the management of NVUGIB.
Participants reported substantive gaps in the implementation of NVUGIB guidelines that included the following: lack of knowledge of the specifics of the NVUGIB guidelines (ER, ICU, nurses); limited belief in the value of guidelines, especially in areas where evidence is lacking (ER, ICU); limited belief in the value of available tools to support implementation of guidelines (GI); lack of knowledge of the roles and responsibilities of health care professions and disciplines, and lack of effective collaboration skills (ER, ICU and GI); variability of knowledge and skills of health care professionals within professions (eg, variability of nurses' knowledge and skills in endoscopic procedures); and perceived overuse of intravenous proton pump inhibitor treatment, with limited concern regarding cost or side effect implications (all participants).
In the present study population, ER, ICU and nurses did not adhere to NVUGIB guidelines because they were neither aware of nor familiar with them, whereas the GI lack of adherence to NVUGIB guidelines was influenced more by attitudinal and contextual barriers. These findings can guide the design of multifaceted educational and behavioural interventions when attempting to effectively disseminate existing guidelines, and for guideline implementation into practice.
Notes
Cites: Can J Gastroenterol. 2004 Sep;18(9):567-7115457296
Cites: N Engl J Med. 2008 Aug 28;359(9):928-3718753649
Cites: Chest. 2009 Mar;135(3 Suppl):49S-55S19265076
Cites: Gastrointest Endosc. 2009 Aug;70(2):229-3519329112
Cites: Am J Manag Care. 2004 Jun;10(6):383-9115209482
Cites: J Crit Care. 2002 Jun;17(2):138-4512096377
Cites: Am J Gastroenterol. 2000 Nov;95(11):3118-2211095327
Cites: Int J Qual Health Care. 2006 Apr;18(2):123-616234299
Cites: J Contin Educ Health Prof. 2006 Winter;26(1):5-1216557510
Cites: J Gen Intern Med. 2006 Feb;21 Suppl 2:S14-2016637955
Cites: Am J Gastroenterol. 2006 Oct;101(10):2200-516952283
Cites: Obstet Gynecol. 2006 Nov;108(5):1234-4517077251
Cites: JAMA. 1999 Oct 20;282(15):1458-6510535437
Cites: J Contin Educ Health Prof. 2007 Spring;27(2):94-10217576625
Cites: Aliment Pharmacol Ther. 2007 Mar 1;25(5):609-1517305762
Cites: JAMA. 1995 Sep 6;274(9):700-57650822
Cites: CMAJ. 1995 Nov 15;153(10):1423-317585368
Cites: Lancet. 1996 Apr 27;347(9009):1138-408609747
Cites: CMAJ. 1997 Aug 15;157(4):408-169275952
Cites: BMJ. 1997 Aug 16;315(7105):418-219277610
Cites: Crit Care Med. 1997 Oct;25(10):1678-849377882
Cites: Intensive Care Med. 1998 Mar;24(3):217-239565802
Cites: BMJ. 1998 Aug 15;317(7156):465-89703533
Cites: JAMA. 1998 Sep 16;280(11):1000-59749483
Cites: Int J Clin Pract. 2005 Jan;59(1):31-415707461
Cites: Ann Pharmacother. 2005 May;39(5):810-615811900
Cites: Cochrane Database Syst Rev. 2005;(3):CD00547016034980
Cites: Can J Gastroenterol. 2005 Aug;19(8):487-9516107900
Cites: Int J Technol Assess Health Care. 2005 Summer;21(3):380-516110718
Cites: Can J Gastroenterol. 2005 Nov;19(11):667-7116292361
Cites: Clin Gastroenterol Hepatol. 2005 Dec;3(12):1207-1416361046
Cites: Am J Gastroenterol. 2004 Jul;99(7):1233-715233659
Cites: Am J Gastroenterol. 2004 Mar;99(3):425-3115056080
Cites: Aliment Pharmacol Ther. 2004 Mar 1;19(5):591-60014987328
Cites: Am J Health Syst Pharm. 2003 Nov 15;60(22):236714652989
Cites: Am Surg. 2002 Feb;68(2):146-5011842960
Cites: Pharmacotherapy. 2001 Jul;21(7):807-1711444577
Cites: BMJ. 2001 Jun 9;322(7299):1413-711397753
Cites: Ann Intern Med. 2003 Nov 18;139(10):843-5714623622
Cites: Aliment Pharmacol Ther. 2003 Jun 15;17(12):1503-612823152
Cites: J Contin Educ Health Prof. 2002 Fall;22(4):237-4312613059
PubMed ID
20485702 View in PubMed
Less detail

Bringing knowledge to action in the context of a major organizational transition.

https://arctichealth.org/en/permalink/ahliterature116745
Source
Health Care Manag (Frederick). 2013 Jan-Mar;32(1):4-12
Publication Type
Article
Author
Marie-Claire Richer
Martin Dawes
Caroline Marchionni
Author Affiliation
Transition Support Office, McGill University Health Centre and Ingram School of Nursing, McGill University, Montreal, Quebec, Canada. marie-claire.richer@muhc.mcgill.ca
Source
Health Care Manag (Frederick). 2013 Jan-Mar;32(1):4-12
Language
English
Publication Type
Article
Keywords
Aged
Decision Making, Organizational
Female
Health Facility Administration
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Organizational Innovation
Qualitative Research
Quebec
Abstract
In the context of organizational transitions in health care institutions, the decisions taken by leaders and clinicians are informed by multiple sources and by a multitude of actors at all levels of the organization. A study was conducted in the context of a major organizational transition at the McGill University Health Centre in Montreal, Quebec, Canada. The purpose was to examine the body of literature around the notions of "evidence" in decision-making processes in health care. Key informants who had a strategic decision-making role linked to the transition activities were interviewed to explore their perceptions of the types of evidence used to support changes in the organization. Results revealed that managers and clinicians relied on multiple sources of evidence and shared similar concerns about reliability and validity of scant evidence.
PubMed ID
23364412 View in PubMed
Less detail

Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators.

https://arctichealth.org/en/permalink/ahliterature166489
Source
Can J Gastroenterol. 2006 Nov;20(11):713-8
Publication Type
Article
Date
Nov-2006
Author
Maida J Sewitch
Pascal Burtin
Martin Dawes
Mark Yaffe
Linda Snell
Mark Roper
Patrizia Zanelli
Alan Pavilanis
Author Affiliation
Department of Medicine, McGill University, Montreal, Canada. maida.sewitch@mcgill.ca
Source
Can J Gastroenterol. 2006 Nov;20(11):713-8
Date
Nov-2006
Language
English
Publication Type
Article
Keywords
Colorectal Neoplasms - diagnosis
Female
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Outcome Assessment (Health Care) - methods
Practice Guidelines as Topic
Quebec
Questionnaires
Retrospective Studies
Risk assessment
Abstract
Physician nonadherence to colorectal cancer (CRC) screening recommendations contributes to underuse of screening.
To assess physicians' knowledge of CRC screening guidelines for average-risk individuals, perceived barriers to screening and practice behaviours.
Between October 2004 and March 2005, staff physicians working in three university-affiliated hospitals in Montreal, Quebec, were surveyed. Self-administered questionnaires assessed knowledge of risk classification and current guidelines for average-risk individuals, as well as perceptions of barriers to screening and practice behaviours.
All 65 invited physicians participated in the survey, including 46 (70.8%) family medicine physicians and 19 (29.2%) general internists. Most physicians knew that screening should begin at 50 years of age, all knew to screen men and women and 92% said they screened average-risk patients. Fifty-seven (87.7%) physicians correctly identified three common characteristics associated with high risk for developing CRC. Physicians who screened average-risk patients preferred fecal occult blood testing (88.3%) and colonoscopy (88.3%) to flexible sigmoidoscopy (10.0%) and double-contrast barium enema (30.0%). Most physicians knew the correct screening periodicity for fecal occult blood testing (87.6%), but only 40% or fewer could identify correct screening periodicities for the other modalities. Barriers and facilitators focused on health care delivery system improvements, better evidence on which to base recommendations and development of practical screening modalities.
Physicians lacked knowledge of the recommended screening modalities and periodicities to appropriately screen average-risk individuals. Because CRC screening can reduce mortality, efforts to improve physician delivery should focus on physician knowledge and changes to the health care delivery system.
Notes
Cites: Arch Intern Med. 2005 Mar 28;165(6):661-615795343
Cites: Acad Radiol. 2005 Apr;12(4):451-815831418
Cites: Ann Intern Med. 2005 Apr 19;142(8):669-7015838075
Cites: Gastroenterology. 2005 May;128(6):1685-9515887159
Cites: N Engl J Med. 2005 May 19;352(20):2061-815901859
Cites: Prev Med. 2005 Jul;41(1):30-515916990
Cites: Gut. 2005 Sep;54(9):1273-815871999
Cites: J Gen Intern Med. 2005 Nov;20(11):989-9516307622
Cites: Health Educ Behav. 1999 Oct;26(5):625-4710533169
Cites: N Engl J Med. 2000 Jul 20;343(3):162-810900274
Cites: Am J Gastroenterol. 2000 Jun;95(6):1551-610894595
Cites: Prev Med. 2000 Oct;31(4):410-611006067
Cites: BMJ. 2000 Oct 21;321(7267):1004-611039973
Cites: Arch Intern Med. 2000 Nov 27;160(21):3209-1411088080
Cites: CMAJ. 2001 Jul 24;165(2):206-811501466
Cites: J Med Screen. 2001;8(3):137-4411678553
Cites: Prev Med. 2001 Nov;33(5):381-9111676578
Cites: Am J Gastroenterol. 2001 Oct;96(10):3004-811693339
Cites: Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):187-9911969233
Cites: Am J Prev Med. 2002 Jul;23(1):28-3512093420
Cites: Prev Med. 1999 Aug;29(2):119-2510446038
Cites: N Engl J Med. 2004 Dec 23;351(26):2704-1415616205
Cites: N Engl J Med. 2004 Dec 23;351(26):2755-815616212
Cites: Prev Med. 2002 Sep;35(3):199-20612202061
Cites: Ann Intern Med. 2002 Jul 16;137(2):129-3112118971
Cites: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):409-1615734966
Cites: Prev Med. 2002 Nov;35(5):447-5212431893
Cites: Prev Med. 2003 Jan;36(1):71-8412473427
Cites: Gastroenterology. 2003 Feb;124(2):544-6012557158
Cites: Prev Med. 2003 Mar;36(3):352-6212634026
Cites: Am J Gastroenterol. 2003 Apr;98(4):915-2312738477
Cites: Am J Gastroenterol. 2003 Jun;98(6):1410-612818289
Cites: N Engl J Med. 2003 Jun 26;348(26):2635-4512826639
Cites: Rep Med Guidel Outcomes Res. 2003 Apr 4;14(7):10, 1212848150
Cites: JAMA. 2003 Jul 9;290(2):191; author reply 19212851267
Cites: Arch Intern Med. 2003 Jul 14;163(13):1601-512860585
Cites: Am J Gastroenterol. 2003 Sep;98(9):2082-9114499792
Cites: Am J Prev Med. 2003 Oct;25(3):187-9414507524
Cites: Can J Gastroenterol. 2004 Apr;18(4):213-915054497
Cites: Can J Surg. 2004 Apr;47(2):104-815132463
Cites: Am J Prev Med. 2004 Jun;26(5):431-515165660
Cites: Am J Gastroenterol. 2004 Jun;99(6):1145-5115180739
Cites: Prev Med. 2004 Aug;39(2):279-8515226036
Cites: Can J Surg. 2004 Jun;47(3):189-9415264381
Cites: Can J Gastroenterol. 2004 Aug;18(8):509-1915372115
Cites: Am J Public Health. 2004 Oct;94(10):1775-8115451749
Cites: N Engl J Med. 1992 Mar 5;326(10):653-71736103
Cites: Lancet. 1996 Nov 30;348(9040):1472-78942775
Cites: Am J Public Health. 1997 Jul;87(7):1190-69240111
Cites: J Natl Cancer Inst. 1999 Mar 3;91(5):434-710070942
PubMed ID
17111053 View in PubMed
Less detail

19 records – page 1 of 2.